Standard of Care Treatment: Managing NPHP
At a Glance
The standard of care for Nephronophthisis (NPHP) focuses on managing chronic kidney disease symptoms, such as salt-wasting and anemia, while preparing for a kidney transplant. Pre-emptive kidney transplants are highly successful, and NPHP does not recur in the new donated kidney.
While there is currently no cure for Nephronophthisis (NPHP), the standard of care is focused on two main goals: managing the symptoms of chronic kidney disease (CKD) to keep your child feeling well and preparing for a successful kidney transplant [1][2].
Managing Symptoms and Complications
Because the kidneys in NPHP cannot concentrate urine or balance minerals effectively, treatment involves addressing several specific areas of health.
Fluid and Salt Balance
One of the most important aspects of NPHP care is managing “salt-wasting” [1][3]. Because the kidneys lose too much salt and water, children with NPHP are at high risk for dehydration.
- Hydration: Your child will likely be encouraged to drink plenty of fluids throughout the day [4].
- Salt Supplements: Some children may need extra salt in their diet or through supplements to replace what is lost in their urine [3].
CRITICAL SAFETY WARNING: Salt supplementation is only appropriate during the “salt-wasting” phase of the disease. In late-stage kidney failure, the kidneys often stop wasting salt and begin retaining it. At this stage, extra salt can cause dangerous fluid overload and high blood pressure. Salt intake must be strictly guided and continuously adjusted by your nephrologist.
Treating Anemia
As kidney function declines, the body produces less erythropoietin, a hormone needed to make red blood cells [5]. This leads to anemia, which causes fatigue and weakness.
- Medications: Doctors may prescribe synthetic erythropoietin injections or iron supplements to help boost red blood cell levels [6][5].
Supporting Growth
Kidney disease can interfere with a child’s natural growth [7]. To help children reach their full height potential, the following may be recommended:
- Nutrition: A specialized diet to ensure they get enough calories and the right balance of minerals [2].
- Growth Hormone: In some cases, recombinant human growth hormone (rhGH) therapy is used to treat growth retardation in children with CKD [8][9].
Blood Pressure and Acid Balance
- Hypertension: While many children with NPHP have normal blood pressure early on, it must be monitored and treated if it becomes high to prevent further kidney damage [7][2].
- Metabolic Acidosis: The kidneys help keep the blood from becoming too acidic. If this balance shifts, doctors may prescribe “bicarbonate” (a type of salt) to neutralize the acid [2].
The Path to Transplant
NPHP almost invariably progresses to End-Stage Renal Disease (ESRD), which is the point where the kidneys can no longer support the body [10][11]. At this stage, a kidney transplant is the preferred treatment [12].
Pre-emptive Transplantation
Whenever possible, medical teams aim for a pre-emptive transplant—a transplant that occurs before the child ever needs to start dialysis [12]. This is often considered the “gold standard” for children because it avoids the physical strain and lifestyle disruptions of dialysis.
Transplant Success and Recurrence
The long-term outlook for children with NPHP after a transplant is very positive [12].
- High Success Rates: Research shows that children with NPHP generally have excellent outcomes and high graft (new kidney) survival rates [12].
- Zero Recurrence: A major benefit for NPHP patients is that the disease does not return in the new kidney [13]. This is especially true for the most common form, NPHP1-related disease, where the risk of recurrence is considered minimal to none [13].
IMPORTANT: A kidney transplant only cures the renal aspect of the disease. It does NOT halt the progression of systemic issues, such as vision loss from Senior-Løken syndrome. Multi-system monitoring must continue after the transplant.
By focusing on careful symptom management during the CKD stage, families can help ensure their child is in the best possible health when it comes time for their transplant [14].
Common questions in this guide
What is salt-wasting in Nephronophthisis?
Will my child with NPHP eventually need a kidney transplant?
Can Nephronophthisis come back after a kidney transplant?
Does a kidney transplant cure all NPHP symptoms?
How is anemia treated in children with Nephronophthisis?
Can NPHP affect my child's physical growth?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is our goal for my child's daily salt and fluid intake to prevent dehydration and salt-wasting?
- 2.How are we monitoring my child's growth, and is recombinant human growth hormone (rhGH) an option if their growth slows down?
- 3.What is my child's current hemoglobin level, and will they need erythropoietin injections or iron supplements for anemia?
- 4.Can we aim for a 'pre-emptive' transplant to avoid dialysis entirely?
- 5.How do we begin the screening process for potential living donors within our family?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
Novel pathogenic MAPKBP1 variant in a family with nephronophthisis.
Al-Hamed MH, Alzaidan H, Hussein M, et al.
Clinical kidney journal 2021; (14(2)):728-730 doi:10.1093/ckj/sfaa090.
PMID: 33623699 - 2
Chronic Kidney Disease and Dietary Measures to Improve Outcomes.
Akchurin OM
Pediatric clinics of North America 2019; (66(1)):247-267 doi:10.1016/j.pcl.2018.09.007.
PMID: 30454747 - 3
Ciliopathy: Senior-Løken Syndrome.
Tsang SH, Aycinena ARP, Sharma T
Advances in experimental medicine and biology 2018; (1085()):175-178 doi:10.1007/978-3-319-95046-4_34.
PMID: 30578507 - 4
Clinical and genetic analyses of a Dutch cohort of 40 patients with a nephronophthisis-related ciliopathy.
Stokman MF, van der Zwaag B, van de Kar NCAJ, et al.
Pediatric nephrology (Berlin, Germany) 2018; (33(10)):1701-1712 doi:10.1007/s00467-018-3958-7.
PMID: 29974258 - 5
Dapafliglozin and Correction of Anemia in Patients with CKD.
Singh AK
NEJM evidence 2023; (2(6)):EVIDe2300095 doi:10.1056/EVIDe2300095.
PMID: 38320136 - 6
Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD).
Babitt JL, Berns JS, Bozkurt B, et al.
Kidney international 2026; (109(1)):44-56 doi:10.1016/j.kint.2025.06.005.
PMID: 41485807 - 7
When Nonspecific Symptoms Conceal Kidney Disease: A Case Report on Recognizing Juvenile Nephronophthisis in Pediatric Practice.
Shah A, Shah A, Lemaire M, et al.
Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners 2026; (40(3)):424-429 doi:10.1016/j.pedhc.2025.08.004.
PMID: 40892003 - 8
Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease.
Drube J, Wan M, Bonthuis M, et al.
Nature reviews. Nephrology 2019; (15(9)):577-589 doi:10.1038/s41581-019-0161-4.
PMID: 31197263 - 9
Bone Disease in CKD in Children.
Santos F, Díaz-Anadón L, Ordóñez FA, Haffner D
Calcified tissue international 2021; (108(4)):423-438 doi:10.1007/s00223-020-00787-z.
PMID: 33452890 - 10
Nephronophthisis.
Srivastava S, Sayer JA
Journal of pediatric genetics 2014; (3(2)):103-14 doi:10.3233/PGE-14086.
PMID: 27625867 - 11
Nephronophthisis: A review of genotype-phenotype correlation.
Luo F, Tao YH
Nephrology (Carlton, Vic.) 2018; (23(10)):904-911 doi:10.1111/nep.13393.
PMID: 29717526 - 12
Long-Term Outcomes of Kidney Transplant Recipients With Juvenile Nephronophthisis.
Avcı B, Baskın E, Gülleroğlu K, et al.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2022; (20(Suppl 3)):122-125 doi:10.6002/ect.PediatricSymp2022.O39.
PMID: 35570616 - 13
A case report of two Chinese monozygotic twins with NPHP1 gene-associated nephronophthisis undergoing kidney transplantation from a related living-donor.
Liu Y, Qiu T, Chen Z, et al.
Transplant immunology 2023; (78()):101828 doi:10.1016/j.trim.2023.101828.
PMID: 36948406 - 14
Genotype and phenotype analysis and transplantation strategy in children with kidney failure caused by NPHP.
Li J, Su X, Zhang H, et al.
Pediatric nephrology (Berlin, Germany) 2023; (38(5)):1609-1620 doi:10.1007/s00467-022-05763-3.
PMID: 36227438
This page provides educational information on managing Nephronophthisis (NPHP). Always consult your pediatric nephrologist regarding your child's specific treatment plan, especially concerning salt intake.
Get notified when new evidence is published on Nephronophthisis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.